Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000228976 | SCV000291118 | likely benign | Dilated cardiomyopathy 1KK | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000252987 | SCV000319023 | likely benign | Cardiovascular phenotype | 2021-02-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000421407 | SCV000536532 | uncertain significance | not provided | 2025-03-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in patients with cardiomyopathy in published literature; several patients harbored additional cardiogenetic variants (PMID: 28798025, 26084686, 35284542, 30847666); This variant is associated with the following publications: (PMID: 26084686, 35284542, 30847666, 28798025) |
Genome Diagnostics Laboratory, |
RCV000228976 | SCV000743690 | uncertain significance | Dilated cardiomyopathy 1KK | 2016-08-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000228976 | SCV000745064 | uncertain significance | Dilated cardiomyopathy 1KK | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000421407 | SCV001147937 | uncertain significance | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001824644 | SCV002074528 | likely benign | not specified | 2022-01-04 | criteria provided, single submitter | clinical testing | Variant summary: MYPN c.3124C>T (p.Arg1042Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00041 in 251424 control chromosomes (gnomAD). The observed variant frequency is approximately 8-fold of the estimated maximal expected allele frequency for a pathogenic variant in MYPN causing Cardiomyopathy phenotype (5e-05), strongly suggesting that the variant is benign. c.3124C>T has been reported in the literature in individuals affected with Cardiomyopathy, including dilated cardiomyopathy, hypertrophic cardiomyopathy and left ventricular hypertrabeculation (Akinrinade_2015, Miszalski-Jamka_2017, van Lint_2019). These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. A co-occurrence with a pathogenic variant has been reported (TTNI3 c.407G>A, p.Arg136Gln; van Lint_2019). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six ClinVar submitters have assessed this variant since 2014: one classified the variant as likely benign and five as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. |
Mayo Clinic Laboratories, |
RCV000421407 | SCV005411014 | uncertain significance | not provided | 2024-04-11 | criteria provided, single submitter | clinical testing | BS1 |
Blueprint Genetics | RCV000143934 | SCV000188812 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2014-10-15 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000228976 | SCV000732958 | uncertain significance | Dilated cardiomyopathy 1KK | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000421407 | SCV001925617 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000421407 | SCV001955114 | uncertain significance | not provided | no assertion criteria provided | clinical testing |